Literature DB >> 16819238

[Drug resistance and cell survival mechanisms for anticancer drugs].

Takayuki Sakai1.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16819238     DOI： 10.1254/fpj.127.342

Source DB:  PubMed          Journal:  Nihon Yakurigaku Zasshi        ISSN： 0015-5691


× No keyword cloud information.
  3 in total

1.  Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol.

Authors:  Qiang-Ling Sun; Hui-Fang Sha; Xiao-Hua Yang; Guo-Liang Bao; Jing Lu; Yin-Yin Xie
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-25       Impact factor: 4.553

2.  Activities of DNA-PK and Ku86, but not Ku70, may predict sensitivity to cisplatin in human gliomas.

Authors:  Cui-Jie Shao; Jun Fu; Hong-Liu Shi; Yong-Gao Mu; Zhong-Ping Chen
Journal:  J Neurooncol       Date:  2008-04-16       Impact factor: 4.130

Review 3.  Anticancer efficacy of a supramolecular complex of a 2-diethylaminoethyl-dextran-MMA graft copolymer and paclitaxel used as an artificial enzyme.

Authors:  Yasuhiko Onishi; Yuki Eshita; Rui-Cheng Ji; Masayasu Onishi; Takashi Kobayashi; Masaaki Mizuno; Jun Yoshida; Naoji Kubota
Journal:  Beilstein J Nanotechnol       Date:  2014-12-01       Impact factor: 3.649
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.